Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

類似資料

• Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
  著者:: Jacobs, Julie, 等
  出版事項: (2015)
• Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
  著者:: Jacobs, Julie, 等
  出版事項: (2018)
• Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
  著者:: Deben, Christophe, 等
  出版事項: (2018)
• The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
  著者:: Deben, Christophe, 等
  出版事項: (2015)
• Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer
  著者:: Van Der Steen, Nele, 等
  出版事項: (2016)